Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Menlo Therapeutics Inc. (MNLO)

5.2   -0.06 (-1.14%) 02-21 16:00
Open: 5.4 Pre. Close: 5.26
High: 5.4496 Low: 5.12
Volume: 466,067 Market Cap: 127M
Menlo Therapeutics Inc is a biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 5.456 - 5.485 5.485 - 5.51
Low: 5.05 - 5.086 5.086 - 5.116
Close: 5.145 - 5.201 5.201 - 5.247

Technical analysis

as of: 2020-02-21 4:32:07 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 7.42     One year: 8.74
Support: Support1: 4.53    Support2: 3.77
Resistance: Resistance1: 6.35    Resistance2: 7.48
Pivot: 5.06
Moving Average: MA(5): 5.28     MA(20): 5.10
MA(100): 4.86     MA(250): 5.57
MACD: MACD(12,26):     Signal(9): -0.02
Stochastic oscillator: %K(14,3): 61.07     %D(3): 64.40
RSI: RSI(14): 49.96
52-week: High: 9.03  Low: 2.69  Change(%): -35.6
Average Vol(K): 3-Month: 18798  10-Days: 23584

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
MNLO has closed below upper band by 36.3%. Bollinger Bands are 33.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 17 Jan 2020 20:56:30 +0000
Health Care Sector Update for 01/17/2020: FOMX,MNLO,SNCA,FTSV,AEMD

Thu, 05 Apr 2018 07:23:51 +0000
5 Best Stocks That IPO’d in Q1

Mon, 11 Nov 2019 15:55:00 +0000
Why Foamix Stock Just Dropped 27.5%

Mon, 11 Nov 2019 11:31:38 +0000
Foamix Pharm And Menlo Therapeutics To Merge - Quick Facts

Tue, 09 Oct 2018 14:22:00 +0000
Menlo Stock Plunges on Phase II Chronic Cough Study Failure

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 24.40
Shares Float (M) 11.47
% Held by Insiders 19.15
% Held by Institutions 85.54
Shares Short (K) 147
Shares Short P. Month (K)

Stock Financials

EPS -2.960
Book Value (p.s.) 3.630
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -36.2
Return on Equity (ttm) -59.7
Qtrly Rev. Growth
Gross Profit (p.s.) -1.736
Sales Per Share
EBITDA (p.s.) -2.980
Qtrly Earnings Growth
Operating Cash Flow (M) -65.30
Levered Free Cash Flow (M) -39.94

Stock Valuations

P/E -1.76
P/E Growth Ratio -0.01
P/BV 1.43
P/S
P/CF -1.94

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.